Moderna (MRNA) PT Lowered to $78 at UBS

February 19, 2025 9:11 AM EST
Get Alerts MRNA Hot Sheet
Price: $64.56 +1.96%

Rating Summary:
    5 Buy, 21 Hold, 4 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 12 | Down: 21 | New: 20
Join SI Premium – FREE
UBS analyst Eliana Merle lowered the price target on Moderna (NASDAQ: MRNA) to $78.00 (from $96.00) while maintaining a Buy rating.

You May Also Be Interested In





Related Categories

Analyst PT Change